Abstract
Changes in expression and dysfunctional signaling of TrkA/B/C receptors and oncogenic Trk fusion proteins are found in neurological diseases and cancers. Here, we describe the development of a first F-18-labeled optimized lead suitable for in vivo imaging of Trk, [F-18]TRACK, which is radiosynthesized with ease from a nonactivated aryl precursor concurrently combining largely reduced P-gp liability and improved brain kinetics compared to previous leads while displaying high on-target affinity and human kinome selectivity.
| Dokumententyp: | Zeitschriftenartikel |
|---|---|
| Fakultät: | Medizin |
| Themengebiete: | 600 Technik, Medizin, angewandte Wissenschaften > 610 Medizin und Gesundheit |
| ISSN: | 0022-2623 |
| Sprache: | Englisch |
| Dokumenten ID: | 63184 |
| Datum der Veröffentlichung auf Open Access LMU: | 19. Jul. 2019 12:12 |
| Letzte Änderungen: | 04. Nov. 2020 13:41 |
